JPWO2020004607A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020004607A5 JPWO2020004607A5 JP2020527674A JP2020527674A JPWO2020004607A5 JP WO2020004607 A5 JPWO2020004607 A5 JP WO2020004607A5 JP 2020527674 A JP2020527674 A JP 2020527674A JP 2020527674 A JP2020527674 A JP 2020527674A JP WO2020004607 A5 JPWO2020004607 A5 JP WO2020004607A5
- Authority
- JP
- Japan
- Prior art keywords
- aptamer
- aqueous liquid
- preparation according
- liquid preparation
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018124390 | 2018-06-29 | ||
| JP2018124390 | 2018-06-29 | ||
| PCT/JP2019/025766 WO2020004607A1 (ja) | 2018-06-29 | 2019-06-28 | アプタマー製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020004607A1 JPWO2020004607A1 (ja) | 2021-07-15 |
| JPWO2020004607A5 true JPWO2020004607A5 (https=) | 2022-03-31 |
| JP7340264B2 JP7340264B2 (ja) | 2023-09-07 |
Family
ID=68986754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020527674A Active JP7340264B2 (ja) | 2018-06-29 | 2019-06-28 | アプタマー製剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210269802A1 (https=) |
| EP (1) | EP3815715B1 (https=) |
| JP (1) | JP7340264B2 (https=) |
| KR (1) | KR102841342B1 (https=) |
| CN (1) | CN112384246B (https=) |
| AU (1) | AU2019292134B2 (https=) |
| BR (1) | BR112020026634A2 (https=) |
| CA (1) | CA3105002A1 (https=) |
| ES (1) | ES2992308T3 (https=) |
| IL (1) | IL279595B2 (https=) |
| MX (1) | MX2020014124A (https=) |
| SG (1) | SG11202012933QA (https=) |
| TW (1) | TWI845521B (https=) |
| WO (1) | WO2020004607A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220137699A (ko) | 2020-02-06 | 2022-10-12 | 가부시키가이샤 리보믹 | 망막하 고반사 병소 또는 망막하 고반사 병소를 수반하는 망막 질환의 치료제 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
| US5847086A (en) * | 1991-06-20 | 1998-12-08 | Centeon L.L.C. | Therapeutic fragments of von Willebrand factor |
| ZA200903562B (en) * | 2006-11-14 | 2010-07-28 | Ribomic Inc | Aptamer against midkine and use thereof |
| CN101317820B (zh) | 2007-04-19 | 2012-02-29 | 中国人民解放军军事医学科学院毒物药物研究所 | 生物亲和性配体分子介导的靶向脂质体,其制 备及其应用 |
| WO2008150495A2 (en) * | 2007-06-01 | 2008-12-11 | Archemix Corp. | Vwf aptamer formulations and methods for use |
| JP2011515685A (ja) * | 2008-03-26 | 2011-05-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 基質結合ビーズを長期間保存する方法 |
| US9052323B2 (en) | 2009-08-27 | 2015-06-09 | The University Of Kansas | Osmolyte mixture for protein stabilization |
| EP2535410A4 (en) | 2010-02-12 | 2014-08-13 | Ribomic Inc | APTAMER FOR FGF2 AND USE THEREOF |
| WO2014116789A1 (en) * | 2013-01-25 | 2014-07-31 | Thymon, Llc | Immunogenic and prophylactic compositions, methods of making same, and method for treating and preventing tnf-mediated disease and hiv-1 infection |
| CA2943772C (en) * | 2014-03-24 | 2022-07-19 | Ribomic Inc. | Aptamer for fgf2 and use thereof |
| EP3161138A4 (en) * | 2014-06-25 | 2017-12-06 | Monsanto Technology LLC | Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression |
| JP2018124390A (ja) | 2017-01-31 | 2018-08-09 | 株式会社沖データ | 画像形成装置及び定着制御方法 |
-
2019
- 2019-06-28 ES ES19825285T patent/ES2992308T3/es active Active
- 2019-06-28 CN CN201980043745.7A patent/CN112384246B/zh active Active
- 2019-06-28 AU AU2019292134A patent/AU2019292134B2/en active Active
- 2019-06-28 MX MX2020014124A patent/MX2020014124A/es unknown
- 2019-06-28 BR BR112020026634-5A patent/BR112020026634A2/pt not_active Application Discontinuation
- 2019-06-28 WO PCT/JP2019/025766 patent/WO2020004607A1/ja not_active Ceased
- 2019-06-28 JP JP2020527674A patent/JP7340264B2/ja active Active
- 2019-06-28 CA CA3105002A patent/CA3105002A1/en active Pending
- 2019-06-28 TW TW108122887A patent/TWI845521B/zh active
- 2019-06-28 IL IL279595A patent/IL279595B2/en unknown
- 2019-06-28 US US17/256,368 patent/US20210269802A1/en active Pending
- 2019-06-28 KR KR1020217002648A patent/KR102841342B1/ko active Active
- 2019-06-28 SG SG11202012933QA patent/SG11202012933QA/en unknown
- 2019-06-28 EP EP19825285.0A patent/EP3815715B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2730681C2 (ru) | Антисмысловые нуклеиновые кислоты | |
| JP6384845B2 (ja) | アンチセンス核酸 | |
| JP2019518037A (ja) | B型肝炎感染症治療用のPAPD5又はPAPD7のmRNA減少用核酸分子 | |
| CN106573920B (zh) | 用于在流感病毒感染中使用的吲哚 | |
| JP2015504650A5 (https=) | ||
| JP2021512629A5 (https=) | ||
| ES2598555T3 (es) | Nuevos oligonucleótidos modificados ricos en guanosina y actividad antiproliferativa de los mismos | |
| JP2010536787A5 (https=) | ||
| JP2016502858A5 (https=) | ||
| AU2017326372B2 (en) | Modified oligonucleotides and methods of use | |
| TW201134482A (en) | Aptamers to β -NGF and their use in treating β -NGF mediated diseases and disorders | |
| CN113905744A (zh) | 经修饰的间隙子寡核苷酸及其使用方法 | |
| JP2010536787A (ja) | Toll様受容体モジュレータ | |
| JP2021521248A5 (https=) | ||
| JP7022069B2 (ja) | ラパドシン(Rapadocins)、受動拡散型ヌクレオシド輸送体1阻害剤及びその使用 | |
| JP2009521934A5 (https=) | ||
| PE20210630A1 (es) | Composicion que comprende el oligonucleotido antisentido y su uso para el tratamiento de la distrofia muscular de duchenne | |
| JP2011515357A5 (https=) | ||
| US20170009230A1 (en) | Compositions for inhibiting dux4 gene expression and uses thereof | |
| JPWO2020004607A5 (https=) | ||
| CN118109469A (zh) | 诱导外显子50的跳读的反义核酸 | |
| CN102516339A (zh) | 嘧啶并嘧啶化合物及其核苷类似衍生物和制备方法及用途 | |
| CN114574496A (zh) | 核苷类衍生物改性的核酸适体sgc8 | |
| US20200123546A1 (en) | Antisense nucleic acid for treating amyotrophy | |
| CN114574495B (zh) | 核苷类衍生物改性的核酸适体r50 |